Trial Profile
A retrospective study investigating long term efficacy and safety in patients with moderate-to-severe plaque psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2017
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record